Equasens Société anonyme (0R9T.L)
EUR 44.15
(1.03%)
EUR 44.15
(1.03%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 219.78 Million EUR | 2.67% |
| 2022 | 214.07 Million EUR | 10.88% |
| 2021 | 193.06 Million EUR | 12.41% |
| 2020 | 171.75 Million EUR | 8.31% |
| 2019 | 158.56 Million EUR | 6.79% |
| 2018 | 148.48 Million EUR | 14.51% |
| 2017 | 129.66 Million EUR | 1.0% |
| 2016 | 128.38 Million EUR | 13.13% |
| 2015 | 113.47 Million EUR | -0.95% |
| 2014 | 114.56 Million EUR | 1.02% |
| 2013 | 113.4 Million EUR | 4.31% |
| 2012 | 108.72 Million EUR | 12.01% |
| 2011 | 97.06 Million EUR | 6.02% |
| 2010 | 91.55 Million EUR | 12.17% |
| 2009 | 81.62 Million EUR | 9.12% |
| 2008 | 74.8 Million EUR | 5.43% |
| 2007 | 70.94 Million EUR | 5.33% |
| 2006 | 67.35 Million EUR | 5.88% |
| 2005 | 63.61 Million EUR | 4.86% |
| 2004 | 60.66 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 53.99 Million EUR | 0.76% |
| 2024 Q2 | 53.99 Million EUR | 0.0% |
| 2023 FY | 219.78 Million EUR | 2.67% |
| 2023 Q2 | 112.62 Million EUR | 100.0% |
| 2023 Q3 | 53.58 Million EUR | -52.42% |
| 2023 Q4 | 53.58 Million EUR | 0.0% |
| 2023 Q1 | 56.31 Million EUR | -49.04% |
| 2022 Q4 | 110.5 Million EUR | 0.0% |
| 2022 Q1 | 51.78 Million EUR | -47.78% |
| 2022 FY | 214.07 Million EUR | 10.88% |
| 2022 Q2 | 103.57 Million EUR | 100.0% |
| 2021 Q2 | 93.9 Million EUR | 100.0% |
| 2021 FY | 193.06 Million EUR | 12.41% |
| 2021 Q3 | 49.58 Million EUR | -47.2% |
| 2021 Q1 | 46.95 Million EUR | -49.96% |
| 2021 Q4 | 99.16 Million EUR | 100.0% |
| 2020 Q1 | 38.96 Million EUR | -52.3% |
| 2020 Q2 | 77.93 Million EUR | 100.0% |
| 2020 FY | 171.75 Million EUR | 8.31% |
| 2020 Q3 | 46.91 Million EUR | -39.8% |
| 2020 Q4 | 93.82 Million EUR | 100.0% |
| 2019 Q2 | 76.87 Million EUR | 100.0% |
| 2019 Q4 | 81.69 Million EUR | 100.0% |
| 2019 Q1 | 38.43 Million EUR | -49.64% |
| 2019 FY | 158.56 Million EUR | 6.79% |
| 2019 Q3 | 40.84 Million EUR | -46.87% |
| 2018 Q2 | 72.15 Million EUR | 100.0% |
| 2018 FY | 148.48 Million EUR | 14.51% |
| 2018 Q4 | 76.32 Million EUR | 100.0% |
| 2018 Q3 | 38.16 Million EUR | -47.11% |
| 2018 Q1 | 36.07 Million EUR | -45.67% |
| 2017 Q1 | 31.63 Million EUR | -51.22% |
| 2017 Q3 | 33.2 Million EUR | -47.52% |
| 2017 Q4 | 66.4 Million EUR | 100.0% |
| 2017 Q2 | 63.26 Million EUR | 100.0% |
| 2017 FY | 129.66 Million EUR | 1.0% |
| 2016 Q4 | 64.85 Million EUR | 100.0% |
| 2016 FY | 128.38 Million EUR | 13.13% |
| 2016 Q2 | 63.52 Million EUR | 100.0% |
| 2016 Q3 | 32.42 Million EUR | -48.96% |
| 2016 Q1 | 31.76 Million EUR | -44.56% |
| 2015 Q1 | 28.09 Million EUR | -50.06% |
| 2015 Q3 | 28.64 Million EUR | -49.02% |
| 2015 Q2 | 56.18 Million EUR | 100.0% |
| 2015 FY | 113.47 Million EUR | -0.95% |
| 2015 Q4 | 57.29 Million EUR | 100.0% |
| 2014 Q4 | 56.24 Million EUR | 100.0% |
| 2014 Q1 | 29.15 Million EUR | -46.27% |
| 2014 FY | 114.56 Million EUR | 1.02% |
| 2014 Q2 | 58.31 Million EUR | 100.0% |
| 2014 Q3 | 28.12 Million EUR | -51.77% |
| 2013 Q3 | 27.13 Million EUR | -54.12% |
| 2013 Q1 | 29.57 Million EUR | 0.0% |
| 2013 FY | 113.4 Million EUR | 4.31% |
| 2013 Q2 | 59.14 Million EUR | 100.0% |
| 2013 Q4 | 54.26 Million EUR | 100.0% |
| 2012 FY | 108.72 Million EUR | 12.01% |
| 2011 FY | 97.06 Million EUR | 6.02% |
| 2010 FY | 91.55 Million EUR | 12.17% |
| 2009 FY | 81.62 Million EUR | 9.12% |
| 2008 FY | 74.8 Million EUR | 5.43% |
| 2007 FY | 70.94 Million EUR | 5.33% |
| 2006 FY | 67.35 Million EUR | 5.88% |
| 2005 FY | 63.61 Million EUR | 4.86% |
| 2004 FY | 60.66 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cegedim SA | 615.99 Million EUR | 64.32% |
| Guerbet SA | 795.65 Million EUR | 72.376% |
| Nexus AG | 241.45 Million EUR | 8.975% |
| Bastide Le Confort Médical SA | 529.75 Million EUR | 58.511% |
| Revenio Group Oyj | 96.57 Million EUR | -127.58% |
| Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | 93.485% |
| Sartorius Aktiengesellschaft | 3.39 Billion EUR | 93.527% |
| LNA Santé SA | 736.08 Million EUR | 70.141% |
| Siemens Healthineers AG | 22.36 Billion EUR | 99.017% |
| Medios AG | 1.78 Billion EUR | 87.685% |
| Stratec SE | 261.91 Million EUR | 16.083% |